We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.49B
Cap. Flow %
-16.94%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126
Avg Time Held Equity + Options
3.2 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.7 quarters
Avg Time Held Equity only
3.2 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.7 quarters

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.77%
3 Healthcare 15.9%
4 Miscellaneous 8.89%
5 Real Estate 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IVCP icon
726
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$929K 0.01%
93,581
-9,368
-9% -$92.6K
2022 Q2
1 quarter
HWEL
727
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$929K 0.01%
95,450
-9,555
-9% -$92.9K
2021 Q4
3 quarters
OCUL icon
728
Ocular Therapeutix
OCUL
$1.59B
$926K 0.01%
223,066
-289,820
-57% -$1.46M
2022 Q1
2 quarters
ACAH
729
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$919K 0.01%
93,581
-9,368
-9% -$91.9K
2021 Q4
3 quarters
SPNE
730
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$915K 0.01%
161,019
+8,936
+6% +$56.8K
2022 Q1
2 quarters
NCLH icon
731
PUT
Norwegian Cruise Line
NCLH
$7.03B
$904K 0.01%
69,200
– –
2021 Q2
5 quarters
BCAB icon
732
DELISTED
BIOATLA INC
BCAB
$862K 0.01%
+2,240
New +$733K
2022 Q3
0 quarters
TRGP icon
733
Targa Resources
TRGP
$62.8B
$854K 0.01%
+14,151
New +$929K
2022 Q3
0 quarters
XOM icon
734
ExxonMobil
XOM
$716B
$829K 0.01%
9,500
-59,786
-86% -$5.46M
2022 Q2
1 quarter
CNTB icon
735
Connect Biopharma Holdings
CNTB
$57.9M
$792K 0.01%
613,931
-37,575
-6% -$45.1K
2022 Q2
1 quarter
SLN icon
736
Silence Therapeutics
SLN
$551M
$786K 0.01%
79,636
+50,820
+176% +$535K
2022 Q2
1 quarter
NVR icon
737
NVR
NVR
$15.4B
$777K 0.01%
195
-302
-61% -$1.29M
2022 Q2
1 quarter
SY icon
738
So-Young International
SY
$267M
$775K 0.01%
1,076,000
– –
2022 Q2
1 quarter
SRRK icon
739
Scholar Rock
SRRK
$4.93B
$757K 0.01%
109,250
-5,750
-5% -$47.9K
2022 Q2
1 quarter
VSTM icon
740
Verastem
VSTM
$675M
$756K 0.01%
74,095
-44,820
-38% -$625K
2022 Q1
2 quarters
ANNX icon
741
Annexon
ANNX
$726M
$752K 0.01%
121,757
-10,093
-8% -$54.6K
2022 Q1
2 quarters
LFG
742
DELISTED
Archaea Energy Inc.
LFG
$751K 0.01%
41,719
-2,815
-6% -$49.5K
2021 Q3
4 quarters
GLUE icon
743
Monte Rosa Therapeutics
GLUE
$844M
$748K 0.01%
91,615
-10,032
-10% -$92.1K
2022 Q1
2 quarters
DAWN icon
744
DELISTED
Day One Biopharmaceuticals
DAWN
$741K 0.01%
+37,000
New +$787K
2022 Q3
0 quarters
AMT icon
745
American Tower
AMT
$83.6B
$736K 0.01%
3,427
-88
-3% -$22.6K
2022 Q2
1 quarter
FLNC icon
746
Fluence Energy
FLNC
$971M
$730K 0.01%
50,000
-50,000
-50% -$755K
2021 Q4
3 quarters
CRC icon
747
California Resources
CRC
$4.82B
$693K 0.01%
18,026
+104
+0.6% +$4.52K
2020 Q4
7 quarters
EXPE icon
748
PUT
Expedia Group
EXPE
$32.8B
$684K 0.01%
13,500
– –
2022 Q2
1 quarter
SGEN
749
DELISTED
Seagen Inc. Common Stock
SGEN
$684K 0.01%
+5,000
New +$815K
2022 Q3
0 quarters
SLB icon
750
SLB Ltd
SLB
$72.4B
$678K 0.01%
+18,894
New +$685K
2022 Q3
0 quarters

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.49B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.